acetylcysteine has been researched along with lidocaine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Dempsey, DT; Mercer, DW; Ritchie, WP | 1 |
| Aleĭnikov, VG; Burushkina, TN; Evdokimenko, VM; Kokarovtseva, MG; Stavinskiĭ, VB | 1 |
| Borzone, S; Caglieris, S; Ghia, M; Giannini, E; Mattioli, F; Mereto, E; Risso, D; Testa, R | 1 |
| Haertel, C; Lenhart, A; Meier-Hellmann, A; Michel, C; Rank, N; Spies, C; Welte, M | 1 |
| Beghetti, M; Giger, R; Lacroix, JS; Landis, BN; Morel, DR; Rimensberger, PC | 1 |
| Del Sorbo, L; Zhang, H | 1 |
| Armstrong, VW; Hein, OV; Kox, WJ; Oellerich, M; Ohring, R; Schilling, A; Spies, C | 1 |
| Hirota, K; Kusunoki, M; Matsuo, Y; Nishi, K; Okamoto, A; Oku, K; Shingu, K; Sumi, C; Takenaga, K; Tanaka, M | 1 |
| Almacioglu, M; Demirkasimoglu, M; Eyison, RK; Ivelik, K; Kenar, L; Kunak, ZI; Ortatatli, M; Sezigen, S | 1 |
1 review(s) available for acetylcysteine and lidocaine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for acetylcysteine and lidocaine
| Article | Year |
|---|---|
N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.
Topics: Acetylcysteine; Adult; Aged; Blood Flow Velocity; Coloring Agents; Double-Blind Method; Female; Free Radical Scavengers; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Liver; Liver Circulation; Liver Function Tests; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; Oxygen Consumption; Prospective Studies; Shock, Septic; Survival Analysis | 2000 |
14 other study(ies) available for acetylcysteine and lidocaine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Do sensory neurons mediate adaptive cytoprotection of gastric mucosa against bile acid injury?
Topics: Acetylcysteine; Adaptation, Physiological; Animals; Bile Acids and Salts; DNA; Gastric Mucosa; Lidocaine; Mucus; Neurons, Afferent; Rats; Rats, Inbred Strains; Taurocholic Acid | 1992 |
[Adsorption of antidotes by carbon hemosorbents].
Topics: Acetylcysteine; Aconitine; Adsorption; Antidotes; Charcoal; Cysteine; Hemoperfusion; In Vitro Techniques; Kinetics; Lidocaine | 1984 |
Effects of reduced glutathione and n-acetylcysteine on lidocaine metabolism in cimetidine treated rats.
Topics: Acetylcysteine; Anesthetics, Local; Animals; Cimetidine; Drug Interactions; Fluorescence Polarization Immunoassay; Free Radical Scavengers; Glutathione; Histamine H2 Antagonists; Injections, Intraperitoneal; Lidocaine; Rats; Rats, Sprague-Dawley; Time Factors | 1998 |
Somato-sympathetic vasoconstriction to intranasal fluid administration with consecutive decrease in nasal nitric oxide.
Topics: Acetylcysteine; Administration, Intranasal; Adult; Anesthetics, Local; Chronic Disease; Expectorants; Female; Histamine; Humans; Laser-Doppler Flowmetry; Lidocaine; Male; Middle Aged; Nasal Mucosa; Nebulizers and Vaporizers; Nitric Oxide; Reflex; Sinusitis; Sodium Chloride; Sympathetic Nervous System; Vasoconstriction | 2003 |
Is there a place for N-acetylcysteine in the treatment of septic shock?
Topics: Acetylcysteine; Antioxidants; Hemodynamics; Humans; Lidocaine; Liver; Liver Circulation; Shock, Septic | 2004 |
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Female; Hemodynamics; Humans; Lactates; Lidocaine; Liver; Liver Circulation; Liver Function Tests; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Shock, Septic; Signal Transduction; Survival Analysis; Vasoconstriction | 2004 |
The antioxidant N-acetyl cysteine suppresses lidocaine-induced intracellular reactive oxygen species production and cell death in neuronal SH-SY5Y cells.
Topics: Acetylcysteine; Anesthetics, Local; Antioxidants; Apoptosis; Bupivacaine; Cell Death; Cell Line, Tumor; Cell Survival; Chromans; Dose-Response Relationship, Drug; HeLa Cells; Humans; Lidocaine; Membrane Potential, Mitochondrial; Mepivacaine; Mitochondria; Neuroblastoma; Reactive Oxygen Species; Time Factors | 2016 |
Victims of chemical terrorism, a family of four who were exposed to sulfur mustard.
Topics: Acetaminophen; Acetylcysteine; Administration, Cutaneous; Administration, Inhalation; Adult; Albuterol; Asian People; Chemical Terrorism; Child, Preschool; Cyclopentolate; Female; Gentamicins; Humans; Infant, Newborn; Lidocaine; Male; Methylprednisolone; Mustard Gas; Silver Sulfadiazine; Skin; Syria; Terrorism; Turkey | 2019 |